S&P 및 Nasdaq 내재가치 문의하기

Repligen Corporation RGEN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
61/100
1/7 Pass
SharesGrow Intrinsic Value
$186.82
+42.6%
Analyst Price Target
$183.00
+39.7%

Repligen Corporation (RGEN) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 EDDLEMAN ROY T 370,000 주 보유. 기타 주요 보유자에는 HERLIHY WALTER C 및 DAWES KAREN A.

지난 12개월간 내부자는 41 건의 거래를 수행 RGEN 주식 — 17 건 매수 (평가액 $9.83M) 및 6 건 매도 (평가액 $1.91M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

RGEN 내부자 보유 현황

최대 보유자
EDDLEMAN ROY T
370,000 주
매수 (12개월)
17
$9.83M 평가액
매도 (12개월)
6
$1.91M 평가액
12개월 거래 활동
매수 41%
매도 15%
내부자 주요 보유자
# 이름 직책 보유 주식수 최종 신고일 상대적 규모
1 Eddleman Roy T 10 Percent Owner 370,000 2018-08-13
100%
2 Herlihy Walter C President, CEO 262,430 2015-05-14
71%
3 Dawes Karen A Director 91,821 2025-12-18
25%
4 Hunt Anthony Director 89,062 2026-03-03
24%
5 Snodgres Jon Chief Financial Officer 37,381 2023-05-16
10%
6 Cooper Glenn L Md Director 35,709 2019-05-28
10%
7 Gebski Christine See Remarks 27,419 2024-05-15
7%
8 Loeillot Olivier Chief Executive Officer 25,890 2026-03-23
7%
9 Ryan Thomas F Jr Director 12,337 2021-11-04
3%
10 Rusche James R Senior Vice President 9,895 2016-03-01
3%
11 Douglass Brian Robb Chief Product Officer 8,319 2026-03-03
2%
12 Bylund James Chief Operating Officer 8,315 2026-03-23
2%
13 Garland Jason K CFO 8,315 2026-03-23
2%
14 Benjamin Howard VP Business Development 8,289 2017-05-22
2%
15 Kuriyel Ralf Senior VP, R&d 5,669 2026-03-23
2%
16 Hughes Violetta Chief Accounting Officer 3,914 2025-09-04
1%
17 Muir Glenn P Director 3,366 2025-12-17
1%
18 Goldberg Alfred Lewis Director 1,992 2015-05-26
1%
19 Pax Margaret Director 1,800 2025-05-19
0%
20 Madaus Martin D Director 1,800 2025-08-12
0%
최근 거래 (최근 12개월)
날짜 이름 직책 유형 주식수 주가 금액
2026-03-05 Loeillot Olivier Chief Executive Officer RSU 부여 25,890 $141.91 $3.67M
2026-03-05 Bylund James Chief Operating Officer RSU 부여 8,315 $141.91 $1.18M
2026-03-05 Garland Jason K CFO RSU 부여 8,315 $141.91 $1.18M
2026-03-05 Kuriyel Ralf Senior VP, R&d RSU 부여 5,669 $141.91 $804.49K
2026-03-04 Bylund James Chief Operating Officer RSU 원천징수 62 $125.84 $7.8K
2026-03-04 Kuriyel Ralf Senior VP, R&d RSU 원천징수 42 $125.84 $5.29K
2026-03-02 Douglass Brian Robb Chief Product Officer RSU 원천징수 221 $124.97 $27.62K
2026-03-02 Loeillot Olivier Chief Executive Officer RSU 원천징수 1,610 $124.97 $201.2K
2026-02-27 Loeillot Olivier Chief Executive Officer RSU 원천징수 344 $128.73 $44.28K
2026-03-02 Bylund James Chief Operating Officer RSU 원천징수 2,433 $124.97 $304.05K
2026-02-27 Bylund James Chief Operating Officer RSU 원천징수 1,478 $128.73 $190.26K
2026-03-02 Garland Jason K CFO RSU 원천징수 715 $124.97 $89.35K
2026-02-27 Garland Jason K CFO RSU 원천징수 327 $128.73 $42.09K
2026-03-02 Kuriyel Ralf Senior VP, R&d RSU 원천징수 923 $124.97 $115.35K
2026-02-27 Kuriyel Ralf Senior VP, R&d RSU 원천징수 444 $128.73 $57.16K
2026-03-02 Hunt Anthony Director RSU 원천징수 9,897 $124.97 $1.24M
2025-12-31 Douglass Brian Robb Chief Product Officer RSU 부여 2,143 $163.86 $351.15K
2025-12-31 Douglass Brian Robb Chief Product Officer 알 수 없음 7,020 $167.72 $1.18M
2025-12-17 Dawes Karen A Director 정보 매도 275 $161.00 $44.28K
2025-12-16 Muir Glenn P Director 옵션 행사 3,366 $26.12 $87.92K
2025-12-04 Hunt Anthony Director 기타 (매도) 2,000 - -
2025-11-25 Loeillot Olivier Chief Executive Officer 정보 매도 7,041 $170.00 $1.2M
2025-11-18 Bylund James Chief Operating Officer 정보 매도 2,191 $151.21 $331.3K
2025-11-13 Hunt Anthony Director 옵션 행사 2,952 $33.87 $99.98K
2025-11-12 Hunt Anthony Director 정보 매도 464 $158.51 $73.55K
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기